Both in Pharmaceuticals
Organogenesis Holdings vs NRX Pharmaceuticals
Over the past year ORGO returned −77.6% and NRXP returned −9.1%; their daily moves had a correlation of 0.00.
ORGO −77.6% NRXP −9.1%Growth of $1, one year, split-adjusted
| Metric | ORGO | NRXP |
|---|---|---|
| Price | $0.8700 | $2.49 |
| Market cap | $111.9M | $107.8M |
| Today | +4.19% | +11.16% |
| 1 month | −35.1% | −15.3% |
| 6 months | −66.0% | −18.4% |
| Year to date | −83.2% | −8.1% |
| 1 year | −78.3% | −12.6% |
| Revenue growth (YoY) | −56.7% | — |
| Gross margin | 100.0% | 38.7% |
| Net margin | −227.0% | −1500.5% |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | 31.8× |
| Net cash | $34.4M | $26.3M |
| Dividend yield | — | — |
| Volatility (60d) | 61.2% | 61.5% |
| Short % of float | 21.7% | 29.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).